Chesley Taft & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $252K | Buy |
|
|||||
|
2025
Q1 | $247K | Sell |
|
|||||
|
2024
Q4 | $309K | Sell |
|
|||||
|
2024
Q3 | $440K | Sell |
|
|||||
|
2024
Q2 | $599K | Sell |
|
|||||
|
2024
Q1 | $545K | Buy |
|
|||||
|
2023
Q4 | $429K | Buy |
|
|||||
|
2023
Q3 | $302K | Hold |
|
|||||
|
2023
Q2 | $269K | Hold |
|
|||||
|
2023
Q1 | $264K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $231K | Sell |
|
|||||
|
2021
Q4 | $222K | Buy |
|